Cagrilintide + Retatrutide
Ask about this stack
Get a grounded answer across clinical evidence, community patterns, and risks.
115
authors mention this stack
55
ran the components concurrently
Cagrilintide + Retatrutide (Cagrilintide + Retatrutide) appears in 115 author journeys (55 as actual concurrent use). Common goals: Weight loss and appetite suppression; weight loss; weight loss and appetite suppression. Typical doses reported: Cagrilintide 0.5mg, Retatrutide 5mg. Reported side effects include: unstated Research: 3 studies discuss two or more of these components together (3 clinical); the components appear across 47 studies in total.
Research support
3 research studies discuss two or more of these components together (3 clinical). Per-component literature:
PubMed/PMC articles mentioning each compound in title or abstract.
Typical doses reported
Community-reported doses are not medical guidance.
How people are running it
37
Recommended / discussed
36
Currently running
26
Planning to run
21
Ran in the past
What people use it for
Sample reported outcomes
- ✓ unstated
- ✓ Not yet realized
- ✓ Down 63 lbs (SW: 270 lbs, CW: 207 lbs)
- ✓ Suppressed appetite ('can’t think about eating'); down 70 lbs after 6 months
- ✓ Successfully broke through weight loss plateau; weight down from 260 lbs to 198 lbs
- ✓ Zero hunger suppression; felt no effect from either peptide
- ✓ Not yet started
- ✓ successfully maintaining weight at 225 lbs (down from starting weight of 350 lbs)
Self-reported community experiences, not verified results.
Sample reported side effects
- ⚠ unstated
- ⚠ Not yet realized
- ⚠ None specified
- ⚠ None
- ⚠ Not yet started
- ⚠ diarrhea from Cagrilintide, zero fatigue
- ⚠ Overactive libido, nausea/aversion to fried food
- ⚠ unspecified